Orange Book product · Generic (ANDA)
SODIUM NITROPRUSSIDE
SODIUM NITROPRUSSIDE
At a glance
Nov 26, 2018
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 26, 2018
7 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM NITROPRUSSIDE
Strength
25MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 210467
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SODIUM NITROPRUSSIDE
- 2017NIPRIDE RTU IN SODIUM CHLORIDE 0.9%Brand (NDA)
NDA 209387 · EXELA PHARMA
- 1982SODIUM NITROPRUSSIDEBrand (NDA)
NDA 018581 · BAXTER HLTHCARE
- —NIPRIDEBrand (NDA)
NDA 017546 · ROCHE
- —NITROPRESSBrand (NDA)
NDA 018450 · ABBVIE
- 2022SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 208923 · AVET LIFESCIENCES
- 2022SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 215846 · SLATE RUN PHARMA
- 2021SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 214971 · BE PHARMS
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211934 · EUGIA PHARMA
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211277 · XIROMED
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 214199 · SLATE RUN PHARMA
- 2019SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211016 · CAPLIN
- 2019SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 210114 · DR REDDYS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
